Associate DirectorPoseida TherapeuticsSan Diego, California, United States
PB0182 - Development of a non-viral gene therapy approach for severe bleeding disorders
Sunday, June 25, 202318:30 – 19:30 ET
OC 30.5 - Expression and Activity of Human Factor VIII (hFVIII) Following Single and Repeat Administration of an Integrating Non-viral Gene Therapy in Multiple Mouse Models of Severe Hemophilia A
Monday, June 26, 202311:45 – 12:00 ET
